Logo image of QIPT

QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis

NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD

2.54  -0.06 (-2.31%)

After market: 2.54 0 (0%)

Fundamental Rating

3

Overall QIPT gets a fundamental rating of 3 out of 10. We evaluated QIPT against 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. While showing a medium growth rate, QIPT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

QIPT had negative earnings in the past year.
In the past year QIPT had a positive cash flow from operations.
In the past 5 years QIPT reported 4 times negative net income.
QIPT had a positive operating cash flow in each of the past 5 years.
QIPT Yearly Net Income VS EBIT VS OCF VS FCFQIPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

QIPT's Return On Assets of -2.99% is in line compared to the rest of the industry. QIPT outperforms 45.79% of its industry peers.
QIPT's Return On Equity of -6.83% is in line compared to the rest of the industry. QIPT outperforms 47.66% of its industry peers.
The Return On Invested Capital of QIPT (0.14%) is worse than 61.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QIPT is significantly below the industry average of 8.14%.
Industry RankSector Rank
ROA -2.99%
ROE -6.83%
ROIC 0.14%
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
QIPT Yearly ROA, ROE, ROICQIPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

QIPT's Operating Margin of 0.14% is on the low side compared to the rest of the industry. QIPT is outperformed by 61.68% of its industry peers.
QIPT's Gross Margin of 71.56% is amongst the best of the industry. QIPT outperforms 89.72% of its industry peers.
QIPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.14%
PM (TTM) N/A
GM 71.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
QIPT Yearly Profit, Operating, Gross MarginsQIPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for QIPT has been increased compared to 1 year ago.
The number of shares outstanding for QIPT has been increased compared to 5 years ago.
QIPT has a worse debt/assets ratio than last year.
QIPT Yearly Shares OutstandingQIPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
QIPT Yearly Total Debt VS Total AssetsQIPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.55, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
QIPT has a Altman-Z score of 0.55. This is in the lower half of the industry: QIPT underperforms 70.09% of its industry peers.
QIPT has a debt to FCF ratio of 4.91. This is a neutral value as QIPT would need 4.91 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.91, QIPT is doing good in the industry, outperforming 76.64% of the companies in the same industry.
A Debt/Equity ratio of 0.74 indicates that QIPT is somewhat dependend on debt financing.
QIPT has a Debt to Equity ratio of 0.74. This is comparable to the rest of the industry: QIPT outperforms 42.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 4.91
Altman-Z 0.55
ROIC/WACC0.02
WACC7.93%
QIPT Yearly LT Debt VS Equity VS FCFQIPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.22 indicates that QIPT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.22, QIPT is doing worse than 65.42% of the companies in the same industry.
A Quick Ratio of 0.87 indicates that QIPT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.87, QIPT is doing worse than 74.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.87
QIPT Yearly Current Assets VS Current LiabilitesQIPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for QIPT have decreased strongly by -55.56% in the last year.
QIPT shows a decrease in Revenue. In the last year, the revenue decreased by -1.77%.
The Revenue has been growing by 32.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-6.15%

3.2 Future

Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
The Revenue is expected to grow by 21.85% on average over the next years. This is a very strong growth
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-1.57%
Revenue Next 2Y2.37%
Revenue Next 3Y3.38%
Revenue Next 5Y21.85%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
QIPT Yearly Revenue VS EstimatesQIPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
QIPT Yearly EPS VS EstimatesQIPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QIPT Price Earnings VS Forward Price EarningsQIPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

QIPT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QIPT is cheaper than 96.26% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 98.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.33
EV/EBITDA 4.47
QIPT Per share dataQIPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A more expensive valuation may be justified as QIPT's earnings are expected to grow with 16.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%

0

5. Dividend

5.1 Amount

QIPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

QUIPT HOME MEDICAL CORP

NASDAQ:QIPT (2/21/2025, 8:00:01 PM)

After market: 2.54 0 (0%)

2.54

-0.06 (-2.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners59.95%
Inst Owner Change-88.59%
Ins Owners9.53%
Ins Owner Change0.82%
Market Cap109.45M
Analysts81.67
Price Target6.67 (162.6%)
Short Float %3.85%
Short Ratio6.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-70.87%
Min EPS beat(2)-124.09%
Max EPS beat(2)-17.65%
EPS beat(4)0
Avg EPS beat(4)-268.22%
Min EPS beat(4)-540.96%
Max EPS beat(4)-17.65%
EPS beat(8)0
Avg EPS beat(8)-528.36%
EPS beat(12)2
Avg EPS beat(12)-246.68%
EPS beat(16)3
Avg EPS beat(16)-229.67%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)-1.16%
PT rev (3m)-0.32%
EPS NQ rev (1m)-49.92%
EPS NQ rev (3m)-200%
EPS NY rev (1m)-700%
EPS NY rev (3m)-700%
Revenue NQ rev (1m)-5.74%
Revenue NQ rev (3m)-9.47%
Revenue NY rev (1m)-1.7%
Revenue NY rev (3m)-5.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF 5.33
P/OCF 3.32
P/B 1.03
P/tB N/A
EV/EBITDA 4.47
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.48
FCFY18.75%
OCF(TTM)0.76
OCFY30.1%
SpS5.61
BVpS2.47
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -6.83%
ROCE 0.18%
ROIC 0.14%
ROICexc 0.15%
ROICexgc 0.5%
OM 0.14%
PM (TTM) N/A
GM 71.56%
FCFM 8.48%
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 4.91
Debt/EBITDA 1.82
Cap/Depr 28.74%
Cap/Sales 5.13%
Interest Coverage 250
Cash Conversion 75.63%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.87
Altman-Z 0.55
F-Score3
WACC7.93%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-1.77%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-6.15%
Revenue Next Year-1.57%
Revenue Next 2Y2.37%
Revenue Next 3Y3.38%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1795.77%
EBIT Next 3Y232.27%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%